Schedule 13D ownership disclosure

KARUNA THERAPEUTICS INC

Security class unavailable · CUSIP: 48576A100

Event date: 2023-01-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,772,441
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-010753
Form type
SC 13D/A
Filer
Karuna Therapeutics, Inc.
CIK
CIK 1771917
Filed
Feb 06, 2023
Reporting period
Jan 12, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub